Did Viking Therapeutics Just Say "Checkmate" to Eli Lilly?

Eli Lilly (NYSE: LLY) is the largest pharmaceutical (and healthcare) company in the world by market capitalization. It boasts more than 49,000 employees and currently leads the fast-growing market for weight management medicines.However, this veritable Goliath might face some competition from a much smaller challenger: Viking Therapeutics (NASDAQ: VKTX), a mid-cap biotech with a mere 48 full-time employees on its payroll. Viking is working on a therapy that could be a game-changer in weight management.Here's what investors need to know.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool